Located on Chromosome 11, this mutation impacts TRPC6 (transient receptor potential cation channel subfamily C member 6). What is its biological consequence — is it benign or pathogenic, and which disease is associated if any?
Pathogenic; Focal segmental glomerulosclerosis 2